PMN310

· ProMis Neurosciences, Inc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PMN310, covering 2025-07-25 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD) [Phase 1]